CVS Health Corporation (CVS) SEC Filings & Earnings Calls

Loss of activist director may reduce pressure for operational changes, but new director brings technology expertise.

“Robbins' resignation not due to disagreement; Heitsenrether brings data/analytics background.”

Elevated cost trends and macro headwinds could impact remainder of year; medical membership decline.

“Company maintains cautious view for remainder of year in light of continued elevated cost trends and potential for macro headwinds.”

Elevated medical utilization

“Utilization persisted at elevated levels in the second quarter of 2026. Although the level of utilization is difficult to accurately predict, utilization beyond current elevated levels may pressure the Company’s Health Care Benefits segment and its health care delivery assets in its Health Services segment in 2026.” · word for word

PBM regulatory pressure

“Legislation and/or regulations seeking to regulate PBM activities in a comprehensive manner have been proposed or enacted in a majority of states and on the federal level.” · word for word

Pharmacy reimbursement pressure

“These increases were largely offset by regulatory-related price reductions on certain drugs, the impact of recent generic drug introductions and pharmacy reimbursement pressure.” · word for word

Elevated cost trends and macro headwinds could pressure future performance

“Company maintains cautious view for remainder of year due to continued elevated cost trends and potential macro headwinds.”

Health Services segment margin pressure from pharmacy client price improvements

“Health Services adjusted operating income decreased $114M due to continued pharmacy client price improvements.”

Elevated utilization pressure

“Utilization persisted at elevated levels in the first quarter of 2026. Although the level of utilization is difficult to accurately predict, utilization beyond current elevated levels may pressure the Company’s Health Care Benefits segment and its health care delivery assets in its Health Services segment in 2026.” · word for word

PBM regulatory risk

“Legislation and/or regulations seeking to regulate PBM activities in a comprehensive manner have been proposed or enacted in a majority of states and on the federal level.” · word for word

Tariff and economic uncertainty

“Changes in the economic environment, including inflation, the implementation of new tariffs or changes in tariffs, including the impact of tariffs on trade relations between the U.S. and foreign countries, and labor and other market dynamics could create exposure for increased costs and supply chain disruptions that can adversely impact consumer demand, the ” · word for word

Medicare Advantage star rating decline

“more than 81% of the Company’s Medicare Advantage members were in plans with 2026 star ratings of at least 4.0 stars, compared to 88% of the Company’s Medicare Advantage members being in plans with 2025 star ratings of at least 4.0 stars” · word for word

Federal government revenue concentration

“Health Care Benefits segment revenues from the federal government accounted for approximately 20% of the Company’s consolidated total revenues in 2025, 2024 and 2023.” · word for word

Inflation Reduction Act impact on Medicare earnings pattern

“During the year ended December 31, 2025, the Health Care Benefits segment’s operating income progression in its Medicare product line was impacted by changes resulting from the Inflation Reduction Act (the “IRA”), which resulted in a shift in the pattern of earnings throughout the year, including lower earnings in the second half of the year compared to the ” · word for word

Competitive pressure in health benefits and PBM

“The health care benefits industry is highly competitive, primarily due to a large number of for-profit and not-for-profit competitors, competitors’ marketing and pricing and a proliferation of competing products” · word for word

Goodwill Impairment Risk

“During the three months ended September 30, 2025, the Company recorded a $5.7 billion goodwill impairment charge related to the Health Care Delivery reporting unit.” · word for word

Litigation Risk

“Legacy litigation charges of $1.2 billion related to two court decisions; opioid litigation charge of $320 million.”

Utilization Pressure

“Utilization persisted at elevated levels through the third quarter of 2025. Further utilization pressure beyond current expectations could result in the future impairment of goodwill.” · word for word

Medicare Advantage Star Rating Decline

“more than 81% of the Company's Medicare Advantage members were in plans with 2026 star ratings of at least 4.0 stars, compared to 88% of the Company's Medicare Advantage members being in plans with 2025 star ratings of at least 4.0 stars.” · word for word

Pharmacy Reimbursement Pressure

“Adjusted operating income decreased $118M, or 7.4%, in the three months ended September 30, 2025 compared to the prior year primarily driven by continued pharmacy reimbursement pressure.”

Goodwill impairment of $5.7B in Health Care Delivery reporting unit indicates significant operational challenges in that segment

“$5.7 billion goodwill impairment charge related to the Health Care Delivery reporting unit” · word for word

Health Services and Pharmacy & Consumer Wellness segments declining, partially offsetting Health Care Benefits improvement

“Adjusted operating income increase driven by Health Care Benefits, partially offset by declines in Health Services and Pharmacy & Consumer Wellness”